Scientists reverse fibrosis in preclinical studies – Lung and Liver The publication reports on a new target: a dopamine receptor. The authors found that the receptor is unique to lung and liver fibroblasts. Stimulating it blocks YAP and TAZ, reducing… Read More ›
Pulmonary fibrosis
Statins may increase risk of interstitial lung abnormalities in smokers
Use of statins may influence susceptibility to or the progression of interstitial lung disease (ILD) in smokers, according to a new study. While some studies have suggested that statins might be beneficial in the treatment of fibrotic lung disease, others… Read More ›